LGT Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34
Closed -$2.69K 558
2025
Q2
$2.69K Buy
+34
New +$2.7K 0.01% 345
2025
Q1
Sell
-1,575
Closed -$157K 573
2024
Q4
$157K Buy
+1,575
New +$162K 0.35% 54
2024
Q3
Sell
-12
Closed -$1.49K 756
2024
Q2
$1.49K Hold
12
﹤0.01% 739
2024
Q1
$1.58K Sell
12
-45
-79% -$5.55K ﹤0.01% 753
2023
Q4
$6.21K Sell
57
-15
-21% -$1.56K 0.01% 579
2023
Q3
$7.41K Sell
72
-7,805
-99% -$841K 0.01% 536
2023
Q2
$909K Buy
7,877
+4,245
+117% +$482K 0.97% 30
2023
Q1
$386K Buy
+3,632
New +$392K 0.72% 31

Other funds holding MRK

LGT Financial Advisors's MRK Position: Q3 2025 in Review

LGT Financial Advisors sold out of Merck (MRK) in Q3 2025, closing a stake of 34 shares — an estimated $2.69K sold.

LGT Financial Advisors first reported a position in MRK in Q1 2023 and held it in 8 quarters. The position peaked at $909K in Q2 2023. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • LGT Financial Advisors reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 34 Merck shares in Q3 2025, an estimated $2.69K.
  • LGT Financial Advisors first reported a position in Merck in Q1 2023 and held it in 8 quarters.
  • LGT Financial Advisors's Merck position peaked at $909K in Q2 2023.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.